Assaf Oron
Corporate Officer/Principal bij BIOMX INC.
Profiel
Assaf Oron is currently the Chief Executive Officer & Director at Evofuel Ltd.
and the Chief Business Officer at BiomX, Inc. He previously served as the Chief Executive Officer at Chondrocyte Ltd., Senior Project Manager at POC Management Consulting, Executive VP-Corporate Development at Evogene Ltd., and Chief Business Officer at BiomX Ltd.
Mr. Oron received his undergraduate and graduate degrees from Tel-Aviv University.
Actieve functies van Assaf Oron
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOMX INC. | Corporate Officer/Principal | 28-10-2019 |
| Evofuel Ltd. | Chief Executive Officer | 01-01-2012 |
Eerdere bekende functies van Assaf Oron
| Bedrijven | Functie | Einde |
|---|---|---|
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Corporate Officer/Principal | 01-10-2019 |
| EVOGENE LTD. | Corporate Officer/Principal | 01-01-2017 |
| Chondrocyte Ltd. | Chief Executive Officer | 01-01-2006 |
| POC Management Consulting | Corporate Officer/Principal | 01-01-2003 |
Opleiding van Assaf Oron
| Tel-Aviv University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| EVOGENE LTD. | Health Technology |
| BIOMX INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| POC Management Consulting | |
| Evofuel Ltd. | |
| Chondrocyte Ltd. | |
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
